Related Experiment Video

Updated: Dec 31, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K

Current Status of the GALAD and BALAD Biomarker Models for Hepatocellular Carcinoma

Lewis R Roberts1

  • 1Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota.

Gastroenterology & Hepatology
|January 2, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.7K
Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
09:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

8.4K

Related Experiment Videos

Last Updated: Dec 31, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.7K
Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
09:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

8.4K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

140
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
140

Articles linked to this work by shared authors, journal, and citation graph.

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Journal of hepatology·2026

Multi-ancestry sequencing analysis in 293,141 participants identifies predisposition DNA repair genes associated with HCC risk.

JHEP reports : innovation in hepatology·2026

Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma.

The oncologist·2026

Molecular Subtypes of Cholangiocarcinoma and Their Translational Implications.

Gastroenterology·2026

Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies 15 risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21.

HGG advances·2026

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Glucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant.

Gastroenterology & hepatology·2026

Sleep and Disorders of Gut-Brain Interaction.

Gastroenterology & hepatology·2026

New Developments in the Treatment of Hepatitis B Virus Infection.

Gastroenterology & hepatology·2026

Impact of Menopause and Clinical Considerations in Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026

Update on Pregnancy in Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026

Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome.

Gastroenterology & hepatology·2026

USP26-mediated stabilization of RAD51 promotes endometrial cancer progression and limits ferroptosis.

Frontiers in oncology·2026

European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma.

Frontiers in urology·2026

Lipid signature in X-ALD: a comparison between phenotypes.

Frontiers in molecular biosciences·2026

Pattern-Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy.

Cancer reports (Hoboken, N.J.)·2026

Oral glucocorticoid dose patterns and organ damage in systemic lupus erythematosus - a nationwide cohort study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us